Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed
Dalen Meeter
Chief Financial Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Appointed
Joshua Stahl
Chief Executive Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Immediately following the Effective Time, Joshua Stahl was appointed as the Company’s Chief Executive Officer and Jason Myers was appointed as the Company’s President.
On February 27, 2025, J.Jill, Inc. (the “Company”) announced that it has appointed Mary Ellen Coyne to serve as the Company’s Chief Executive Officer and President to succeed the Company’s current Chief Executive Officer and President, Claire Spofford, following Ms. Spofford’s previously disclosed decision to retire.
On February 24, 2025, Michael D. Cahill, VWF Bancorp Inc.'s (the "Company") President and Chief Executive Officer, a member of the Board of Directors of the Company, the Company's subsidiary GreenWay Bank's (the "Bank") President and Chief Executive Officer, and a member of the Board of Directors of the Bank, notified the Company and the Bank that he will retire from the Company and the Bank, at the end of the current term of his employment agreement, effective December 31, 2025.
Departed
Steven Tuch
Executive Vice President and Chief Financial Officer
On February 24, 2025, Steven Tuch, Executive Vice President and Chief Financial Officer of vTv Therapeutics Inc. (the "Company"), informed the Company of his intention to resign from his position effective March 21, 2025.
On February 25, 2025, the Company’s Board of Directors appointed Navam Welihinda as Elastic’s Chief Financial Officer, effective as of February 28, 2025, to succeed Eric Prengel.
Eric Prengel, who has served as the Interim Chief Financial Officer of the Company since December 14, 2024, will cease to serve in this role on February 28, 2025 upon the effectiveness on that date of the appointment of Navam Welihinda as the Company’s Chief Financial Officer
Appointed
Samuel Knipper
Chief Financial Officer
Innovation1 Biotech Inc.
Effective
2025-02-23
Filed
February 27, 2025, 6:59 PM ET
On February 23, 2025, Innovation1 Biotech Inc. (the “Company”) appointed Samuel Knipper to serve as chief financial officer of the Company.
David Lazar, the Company’s interim Chief Executive Officer, interim principal financial officer, interim principal accounting officer, and Secretary, provided notice of his resignation as Chief Executive Officer and Secretary of the Company effective February 26, 2025.
the Board appointed Datuk Dr. Doris Wong Sing Ee, as Chief Executive Officer and, in such role, she will serve as the Company’s principal executive officer.
the Board appointed Niccolo de Masi to serve as President and Chief Executive Officer of the Company, succeeding Peter Chapman effective as of February 26, 2025
Effective as the Effective Date, Mr. Frinzi has agreed to step down at the request of the Board from his positions as President and Chief Executive Officer, and he will cease to serve as a member of the Board of Directors and Board Chair and all other positions with the Company and its subsidiaries.
On February 26, 2025, AlTi Global, Inc. (the “Company”) announced the appointment of Michael W. Harrington as the Company’s Chief Financial Officer and the departure of Stephen Yarad as Chief Financial Officer of the Company.
On February 26, 2025, AlTi Global, Inc. (the “Company”) announced the appointment of Michael W. Harrington as the Company’s Chief Financial Officer and the departure of Stephen Yarad as Chief Financial Officer of the Company.
On February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of Enovis Corporation (the “Company”) of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company.
Departed
Niccolo de Masi
Chief Executive Officer
dMY Squared Technology Group, Inc.
Effective
2025-02-26
Successor
Harry L. You
Filed
February 26, 2025, 6:59 PM ET
On February 26, 2025, Niccolo de Masi, an officer and a member of the Board of Directors (the “Board”) of dMY Squared Technology Group, Inc. (the “Company”), notified the Company of his decision to resign as Chief Executive Officer of the Company and as a member of the Board, effective immediately, in order to pursue another opportunity.
Role change
Harry L. You
Chief Executive Officer
dMY Squared Technology Group, Inc.
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
Effective February 26, 2025, Harry L. You, the Company’s Chief Financial Officer and Chairman, was appointed as Chief Executive Officer of the Company.
On February 20, 2025, Mr. Ying Cao resigned from his position as the chief financial officer (“ CFO ”) of Singularity Future Technology Ltd. (the “ Company ”).
On February 21, 2025, the board of directors of the Company (the “ Board ”) appointed Mr. Chee Jiong Ng as the CFO of the Company to fill the vacancy resulting from Mr. Ying Cao’s resignation.
the Board of Directors (the “Board”) has appointed Michael (Mike) Milotich as Interim Chief Executive Officer (principal executive officer), effective immediately.
On February 26, 2025, Athene Holding Ltd. (the “Company”) announced that Louis-Jacques Tanguy had been appointed Executive Vice President and Chief Financial Officer of the Company, with such appointment to be effective as of March 1, 2025.
Role change
Martin P. Klein
Executive Vice President and Chief Financial Officer
Effective upon Mr. Tanguy’s appointment as described above, Mr. Klein retired from his position as Executive Vice President and Chief Financial Officer of the Company and assumed the role of Senior Advisor with the Company.
Appointed
William Wagner
Chief Executive Officer
SEMrush Holdings, Inc.
Effective
2025-03-10
Filed
February 26, 2025, 6:59 PM ET
On February 22, 2025, William Wagner, age 57, was appointed by the Board as the CEO, effective as of the Transition Date.
On February 25, 2025, Michael P. Scarpelli notified Snowflake Inc. (the “ Company ”) of his intention to retire as the Company’s Chief Financial Officer.
On February 20, 2025, Marcy D. Mutch notified First Interstate BancSystem, Inc. (the “Company”) of her intention to retire as a full-time employee at the end of 2025 and to step down after a transition period as the Company’s Executive Vice President and Chief Financial Officer (“CFO”) effective May 31, 2025 (the “Retirement”).
Jamie Miller, the Company’s Executive Vice President, Chief Financial Officer, has been appointed to the expanded role of Chief Financial and Operating Officer
who notified the Company on the Effective Date that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Effective as of February 19, 2025 (the “Effective Date”), LiveOne, Inc. (the “Company”) appointed Ryan Carhart, the Company’s current Vice President and Controller, as the Company’s Chief Financial Officer, Treasurer and Secretary, to succeed Aaron Sullivan
Departed
Aaron Sullivan
Executive Vice President, Chief Financial Officer, Treasurer and Secretary
Effective as of February 19, 2025 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Ryan Carhart, the Company’s current Vice President and Controller, as the Company’s Chief Financial Officer, Treasurer and Secretary, to succeed Aaron Sullivan
Departed
Robert Mattacchione
Chief Executive Officer
Novo Integrated Sciences, Inc.
Effective
2025-03-07
Filed
February 25, 2025, 6:59 PM ET
on February 20, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to no later than March 7, 2025, in order to provide the Company the necessary time to complete an efficient transition of the Chief Executive Officer position.
each of Mr. Harout Semerjian, the Chief Executive Officer of the Company and Mr. Brian Hahn, the Company’s Chief Financial Officer, ceased his respective employment with the Company as of February 21, 2025
each of Mr. Harout Semerjian, the Chief Executive Officer of the Company and Mr. Brian Hahn, the Company’s Chief Financial Officer, ceased his respective employment with the Company as of February 21, 2025
Departed
(interim)
Peter Rawlinson
Chief Executive Officer and Chief Technology Officer
On February 25, 2025, Lucid Group, Inc. (“ Lucid ” or the “ Company ”) announced that Peter Rawlinson, the Company’s Chief Executive Officer (“ CEO ”) and Chief Technology Officer, resigned from his positions and the Company’s board of directors (the “ Board ”) on February 21, 2025 (the “ Effective Date ”).
On the Effective Date, in connection with Mr. Rawlinson’s departure, the Board appointed Marc Winterhoff, the current Chief Operating Officer (“ COO ”) of the Company, as Interim CEO, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.